Surgical interventions, like all other therapeutic approaches for the treatment of obesity, do not address the root cause, as the actual cause of obesity is complex and still largely unknown. According to guidelines in developed countries, the indication for surgical intervention is given in the following cases:
BMI ≥ 40 kg/m², conservative treatment measures (nutritional, exercise, behavioral, and pharmacotherapy alone or in combination) have proven to be unsuccessful.
BMI ≥ 35 kg/m² with one or more obesity-associated comorbidities such as type 2 diabetes mellitus, coronary heart disease, heart failure, hyperlipidemia, arterial hypertension, nephropathy, obstructive sleep apnea syndrome, obesity hypoventilation syndrome, Pickwick syndrome, non-alcoholic fatty liver or non-alcoholic steatohepatitis, gastroesophageal reflux disease, asthma, chronic venous insufficiency, urinary incontinence, immobilizing joint disease, fertility restrictions, or polycystic ovary syndrome.
Primary indication without prior conservative therapy attempt:
- BMI ≥ 50 kg/m²
- Conservative therapy attempt is deemed unpromising or futile by the multidisciplinary team.
- In patients with particularly severe comorbidities that do not allow postponement of surgical intervention.
A primary indication in terms of metabolic surgery can be made with a BMI ≥ 40 kg/m² and coexisting type 2 diabetes mellitus, when the treatment goal is more focused on improving glycemic metabolism than on weight reduction. For these patients, proof of exhausted conservative therapy in terms of bariatric surgery is not required [American Diabetes Association 2017].
When choosing the procedure, the following parameters should be considered:
- the patient's initial weight (BMI)
- the expected weight loss (EWL)
- compliance
- the age
- a possible desire for children in women
- comorbidities (especially diabetes mellitus)
- the surgical risk
Other factors to consider are:
- gender
- occupation
- dietary habits
There is no universally recommended surgical procedure for all patients; rather, the choice of procedure should be individually tailored to the medical, psychosocial, and general life circumstances of the patient.
All procedures should ideally be performed laparoscopically.
The Mini Gastric Bypass (MGB) is also known as a single anastomosis bypass. Its advantage is a procedure with gastroenterostomy as the only anastomosis, eliminating all complications related to the foot-point anastomosis.
The Mini Gastric Bypass, abbreviated MGB, is considered a safe and effective procedure in bariatric and metabolic surgery. The principle of MGB is the formation of a long lesser curvature gastric pouch combined with a biliary small intestine loop, the length of which can vary. Typically, it measures 200 cm from the Treitz ligament to the gastrojejunostomy. Depending on the severity of obesity, longer biliary limbs (250-300 cm) are also chosen. For severe obesity, a length of 250 cm is recommended, for older patients and vegetarians a length of 180-200 cm, and for type 2 diabetics without massive obesity a length of 150 cm is recommended.